Synergistic Inhibition of Triple-Negative Breast Cancer by Acetylsalicylic Acid and Recombinant Human APE1/Ref-1 in a Mouse Xenograft Model
<b>Background:</b> Triple-negative breast cancer (TNBC) is a highly aggressive subtype with limited therapeutic options due to the lack of estrogen, progesterone, and HER2 receptors. This study investigated the synergistic anticancer effects of recombinant human apurinic/apyrimidinic endonuclease 1/...
Gardado en:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2025-11-01
|
| Series: | Biomedicines |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/2227-9059/13/11/2767 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|